{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:53:04Z","timestamp":1789753984984,"version":"4.0.1"},"reference-count":132,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH-NIDCR","award":["RO1-DE022552"],"award-info":[{"award-number":["RO1-DE022552"]}]},{"name":"NIH-NIDCR","award":["RO1 DE12880"],"award-info":[{"award-number":["RO1 DE12880"]}]},{"name":"UCLA Academic senate","award":["RO1-DE022552"],"award-info":[{"award-number":["RO1-DE022552"]}]},{"name":"UCLA Academic senate","award":["RO1 DE12880"],"award-info":[{"award-number":["RO1 DE12880"]}]},{"name":"School of Dentistry Seed","award":["RO1-DE022552"],"award-info":[{"award-number":["RO1-DE022552"]}]},{"name":"School of Dentistry Seed","award":["RO1 DE12880"],"award-info":[{"award-number":["RO1 DE12880"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>This study found a strong link between interferon-gamma (IFN-\u03b3) secretion from immune cells and changes in bone quality in pancreatic tumor-bearing humanized-BLT (hu-BLT) mice. Tumor presence in hu-BLT mice led to bone resorption and reduced IFN-\u03b3 production compared to healthy mice. Interestingly, oral supplementation with probiotic bacteria AJ2, either alone or combined with supercharged NK (sNK) cells, inhibited tumor growth and increased IFN-\u03b3 levels in tissue compartments and tumor sites. Enhanced IFN-\u03b3 secretion was observed in cell cultures from the pancreas, spleen, PBMCs, splenocyte-derived NK cells, and bone marrow of mice treated with sNK cells and AJ2 compared to untreated tumor-bearing mice. Higher IFN-\u03b3 levels were associated with improved bone integrity in hu-BLT mice. TRAP staining showed increased osteoclastic activity and bone resorption in untreated tumor mice, in contrast to those treated with sNK and AJ2. This research highlights the role of immune cell-derived IFN-\u03b3 in preventing tumor-induced bone loss and improving bone quality, suggesting that probiotics, alone or with immunotherapies, have potential as treatments for osteolytic cancers.<\/jats:p>","DOI":"10.3390\/cells14171347","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T16:18:15Z","timestamp":1756484295000},"page":"1347","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Natural Killer Cell Therapy Combined with Probiotic Bacteria Supplementation Restores Bone Integrity in Cancer by Promoting IFN-\u03b3 Production"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1936-5985","authenticated-orcid":false,"given":"Kawaljit","family":"Kaur","sequence":"first","affiliation":[{"name":"Division of Oral Biology and Medicine, The Jane and Jerry Weintraub Center for Reconstructive Biotechnology, Department of Dentistry, University of California Los Angeles (UCLA), Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Reese","sequence":"additional","affiliation":[{"name":"Division of Oral Biology and Medicine, The Jane and Jerry Weintraub Center for Reconstructive Biotechnology, Department of Dentistry, University of California Los Angeles (UCLA), Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2896-1930","authenticated-orcid":false,"given":"Jason","family":"Chiang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Ronald Reagan UCLA Medical Center, Los Angeles, CA 90095, USA"},{"name":"The Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahid","family":"Jewett","sequence":"additional","affiliation":[{"name":"Division of Oral Biology and Medicine, The Jane and Jerry Weintraub Center for Reconstructive Biotechnology, Department of Dentistry, University of California Los Angeles (UCLA), Los Angeles, CA 90095, USA"},{"name":"The Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kopitar-Jerala, N. (2017). The Role of Interferons in Inflammation and Inflammasome Activation. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.00873"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1158\/1078-0432.CCR-11-0482","article-title":"The Two Faces of Interferon-\u03b3 in Cancer","volume":"17","author":"Zaidi","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41586-019-0988-7","article-title":"Structure of the IFN\u03b3 receptor complex guides design of biased agonists","volume":"567","author":"Mendoza","year":"2019","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s12253-015-9938-3","article-title":"Decreased Interferon \u03b3 Production in CD3+ and CD3- CD56+ Lymphocyte Subsets in Metastatic Regional Lymph Nodes of Melanoma Patients","volume":"21","year":"2015","journal-title":"Pathol. Oncol. Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Han, J., Wu, M., and Liu, Z. (2023). Dysregulation in IFN-\u03b3 signaling and response: The barricade to tumor immunotherapy. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1190333"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lee, H.J., Koh, J., and Kim, J. (2012). INF-\u03b3 production of NK cells is suppressed in cancer patients. (45.10). J. Immunol., 188.","DOI":"10.4049\/jimmunol.188.Supp.45.10"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1101\/cshperspect.a028480","article-title":"Interferon \u03b3 and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity","volume":"11","author":"Alspach","year":"2019","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"30412","DOI":"10.1074\/jbc.272.48.30412","article-title":"Interaction of NF-kappaB and NFAT with the interferon-gamma promoter","volume":"272","author":"Sica","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, directs Th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","article-title":"Regulation of interferon-gamma during innate and adaptive immune responses","volume":"96","author":"Schoenborn","year":"2007","journal-title":"Adv. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.0105-2896.2005.00337.x","article-title":"Interplay between interferon and other cytokine systems in bone metabolism","volume":"208","author":"Takayanagi","year":"2005","journal-title":"Immunol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1634\/stemcells.2008-0886","article-title":"Autocrine regulation of interferon gamma in mesenchymal stem cells plays a role in early osteoblastogenesis","volume":"27","author":"Duque","year":"2009","journal-title":"Stem. Cells"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jaci.2010.11.050","article-title":"Interleukins, from 1 to 37, and interferon-[gamma]: Receptors, functions, and roles in diseases","volume":"127","author":"Akdis","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrrheum.2009.217","article-title":"Osteoimmunology and the effects of the immune system on bone","volume":"5","author":"Takayanagi","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1138\/20060251","article-title":"Is IFN-c involved in bone loss or protection? Nothing is simple with cytokines","volume":"4","author":"Ferrari","year":"2007","journal-title":"Bonekey Osteovision"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/35046102","article-title":"T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma","volume":"408","author":"Takayanagi","year":"2000","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0765.2011.01352.x","article-title":"Locally administered interferon-c accelerates lipopolysaccharide-induced osteoclastogenesis independent of immunohistological RANKL upregulation","volume":"46","author":"Ukai","year":"2011","journal-title":"J. Periodontal Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1172\/JCI30074","article-title":"IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation","volume":"117","author":"Gao","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00109-004-0612-6","article-title":"Mechanistic insight into osteoclast differentiation in osteoimmunology","volume":"83","author":"Takayanagi","year":"2005","journal-title":"Mol. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1056\/NEJM200007133430207","article-title":"The immune system. Second of two parts","volume":"343","author":"Delves","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/jbmr.350","article-title":"Interferon g plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice","volume":"26","author":"Duque","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.cdd.4402170","article-title":"NK cells at the interface between innate and adaptive immunity","volume":"15","author":"Moretta","year":"2008","journal-title":"Cell Death Differ."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"111251","DOI":"10.1016\/j.apradiso.2024.111251","article-title":"Investigation of NK cell function against two target hematological cell line using radioactive chromium assay","volume":"206","year":"2024","journal-title":"Appl. Radiat. Isot."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1056\/NEJMoa1200503","article-title":"HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1","volume":"367","author":"Venstrom","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00262-010-0904-3","article-title":"A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer","volume":"59","author":"Iliopoulou","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","article-title":"Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer","volume":"105","author":"Miller","year":"2005","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/cncr.22002","article-title":"Killer cell Ig-like receptors ligand-mismatched, alloreactive natural killer cells lyse primary solid tumors","volume":"107","author":"Re","year":"2006","journal-title":"Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/14653249.2010.515582","article-title":"A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer","volume":"13","author":"Geller","year":"2011","journal-title":"Cytotherapy"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41577-022-00732-1","article-title":"Roles of natural killer cells in immunity to cancer, and applications to immunotherapy","volume":"23","author":"Wolf","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12967-022-03437-0","article-title":"Natural killer cells: A promising immunotherapy for cancer","volume":"20","author":"Chu","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Portale, F., and Di Mitri, D. (2023). NK Cells in Cancer: Mechanisms of Dysfunction and Therapeutic Potential. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24119521"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41423-021-00808-3","article-title":"Advances in NK cell production","volume":"19","author":"Fang","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000278713","article-title":"An aggressive extramedullary cutaneous plasmacytoma associated with extreme alterations in the innate immune system","volume":"33","author":"Jurisic","year":"2010","journal-title":"Onkologie"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"13028","DOI":"10.1073\/pnas.1000546107","article-title":"Natural killer cells trigger osteoclastogenesis and bone destruction. in arthritis","volume":"107","author":"Soderstrom","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","first-page":"18","article-title":"Anti-cytokine therapy in chronic destructive arthritis","volume":"3","year":"2001","journal-title":"Arthritis Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/bcmd.1995.0028","article-title":"Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease","volume":"21","author":"Bemiller","year":"1995","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1182\/blood-2009-11-255026","article-title":"Cross talk between the bone and immune systems: Osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells","volume":"116","author":"Li","year":"2010","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Kaur, K., Cook, J., Park, S.H., Topchyan, P., Kozlowska, A., Ohanian, N., Fang, C., Nishimura, I., and Jewett, A. (2017). Novel Strategy to Expand Super-Charged NK Cells with Significant Potential to Lyse and Differentiate Cancer Stem Cells: Differences in NK Expansion and Function between Healthy and Cancer Patients. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.00297"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e000676","DOI":"10.1136\/bmjonc-2024-000676","article-title":"Osteoclast-expanded supercharged NK cells perform superior antitumour effector functions","volume":"4","author":"Ko","year":"2025","journal-title":"BMJ Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"357ra123","DOI":"10.1126\/scitranslmed.aaf2341","article-title":"Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia","volume":"8","author":"Romee","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Terr\u00e9n, I., Orrantia, A., Astarloa-Pando, G., Amarilla-Irusta, A., Zenarruzabeitia, O., and Borrego, F. (2022). Cytokine-Induced Memory-Like NK Cells: From the Basics to Clinical Applications. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.884648"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Kaur, K., Safaie, T., Ko, M.-W., Wang, Y., and Jewett, A. (2021). ADCC against MICA\/B Is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like\/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor. Cancers, 13.","DOI":"10.3390\/cancers13020239"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e000618","DOI":"10.1136\/bmjonc-2024-000618","article-title":"Supercharged NK cells, unlike primary activated NK cells, effectively target ovarian cancer cells irrespective of MHC-class I expression","volume":"4","author":"Chen","year":"2025","journal-title":"BMJ Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Kaur, K., Kozlowska, A.K., Topchyan, P., Ko, M.W., Ohanian, N., Chiang, J., Cook, J., Maung, P.O., Park, S.H., and Cacalano, N. (2019). Probiotic-Treated Super-Charged NK Cells Efficiently Clear Poorly Differentiated Pancreatic Tumors in Hu-BLT Mice. Cancers, 12.","DOI":"10.3390\/cancers12010063"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Bui, V.T., Tseng, H.C., Kozlowska, A., Maung, P.O., Kaur, K., Topchyan, P., and Jewett, A. (2015). Augmented IFN-\u03b3 and TNF-\u03b1 Induced by Probiotic Bacteria in NK Cells Mediate Differentiation of Stem-Like Tumors Leading to Inhibition of Tumor Growth and Reduction in Inflammatory Cytokine Release; Regulation by IL-10. Front. Immunol., 6.","DOI":"10.3389\/fimmu.2015.00576"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e1426518","DOI":"10.1080\/2162402X.2018.1426518","article-title":"Super-charged NK cells inhibit growth and progression of stem-like\/poorly differentiated oral tumors in vivo in humanized BLT mice; effect on tumor differentiation and response to chemotherapeutic drugs","volume":"7","author":"Kaur","year":"2018","journal-title":"Oncoimmunology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1017\/S0007114511005824","article-title":"Comparative effects of six probiotic strains on immune function in vitro","volume":"108","author":"Dong","year":"2012","journal-title":"Br. J. Nutr."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Ko, M.-W., Kaur, K., Safaei, T., Chen, W., Sutanto, C., Wong, P., and Jewett, A. (2022). Defective Patient NK Function Is Reversed by AJ2 Probiotic Bacteria or Addition of Allogeneic Healthy Monocytes. Cells, 11.","DOI":"10.3390\/cells11040697"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Chen, Y., Wang, X., Zhang, C., Liu, Z., Li, C., and Ren, Z. (2022). Gut Microbiota and Bone Diseases: A Growing Partnership. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.877776"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00198-024-07320-0","article-title":"Gut microbiome and bone health: Update on mechanisms, clinical correlations, and possible treatment strategies","volume":"36","author":"Ticinesi","year":"2025","journal-title":"Osteoporos. Int."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e28435","DOI":"10.1016\/j.heliyon.2024.e28435","article-title":"Microbiota metabolites in bone: Shaping health and Confronting disease","volume":"10","author":"Han","year":"2024","journal-title":"Heliyon"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Cristofori, F., Dargenio, V.N., Dargenio, C., Miniello, V.L., Barone, M., and Francavilla, R. (2021). Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.578386"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"454","DOI":"10.22203\/eCM.v041a29","article-title":"Gut microbial-derived short-chain fatty acids and bone: A potential role in fracture healing","volume":"41","author":"Wallimann","year":"2021","journal-title":"Eur. Cell Mater."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41467-017-02490-4","article-title":"Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss","volume":"9","author":"Lucas","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Gul, S., and Durante-Mangoni, E. (2024). Unraveling the Puzzle: Health Benefits of Probiotics-A Comprehensive Review. J. Clin. Med., 13.","DOI":"10.3390\/jcm13051436"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Maftei, N.M., Raileanu, C.R., Balta, A.A., Ambrose, L., Boev, M., Marin, D.B., and Lisa, E.L. (2024). The Potential Impact of Probiotics on Human Health: An Update on Their Health-Promoting Properties. Microorganisms, 12.","DOI":"10.3390\/microorganisms12020234"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Ranjha, M.M.A.N., Shafique, B., Batool, M., Kowalczewski, P.\u0141., Shehzad, Q., Usman, M., Manzoor, M.F., Zahra, S.M., Yaqub, S., and Aadil, R.M. (2021). Nutritional and Health Potential of Probiotics: A Review. Appl. Sci., 11.","DOI":"10.3390\/app112311204"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Chu, X., Xing, H., Chao, M., Xie, P., and Jiang, L. (2025). Gut Microbiota Modulation in Osteoporosis: Probiotics, Prebiotics, and Natural Compounds. Metabolites, 15.","DOI":"10.3390\/metabo15050301"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41413-023-00264-x","article-title":"Modulation of bone remodeling by the gut microbiota: A new therapy for osteoporosis","volume":"11","author":"Lyu","year":"2023","journal-title":"Bone Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00223-018-0403-7","article-title":"Advances in Probiotic Regulation of Bone and Mineral Metabolism","volume":"102","author":"McCabe","year":"2018","journal-title":"Calcif. Tissue Int."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Guder, C., Gravius, S., Burger, C., Wirtz, D.C., and Schildberg, F.A. (2020). Osteoimmunology: A Current Update of the Interplay Between Bone and the Immune System. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00058"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev.immunol.24.021605.090646","article-title":"OSTEOIMMUNOLOGY: Interplay Between the Immune System and Bone Metabolism","volume":"24","author":"Walsh","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"ref_65","unstructured":"Brandelli, A. (2022). Chapter 16\u2014Immunomodulatory and antiinflammatory mechanisms of probiotics. Probiotics, Academic Press."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Mazziotta, C., Tognon, M., Martini, F., Torreggiani, E., and Rotondo, J.C. (2023). Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health. Cells, 12.","DOI":"10.3390\/cells12010184"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11914-015-0292-x","article-title":"Prebiotic and Probiotic Regulation of Bone Health: Role of the Intestine and its Microbiome","volume":"13","author":"McCabe","year":"2015","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2009-04-215855","article-title":"A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model","volume":"115","author":"Shimizu","year":"2010","journal-title":"Blood"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"E1408","DOI":"10.1073\/pnas.1115050108","article-title":"Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells","volume":"108","author":"Vatakis","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/14789450.2020.1845654","article-title":"Multiomic analysis of cytokines in immuno-oncology","volume":"17","author":"Jurisic","year":"2020","journal-title":"Expert. Rev. Proteom."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/sj.embor.7401099","article-title":"Interleukin 2: From immunostimulation to immunoregulation and back again","volume":"8","author":"Bachmann","year":"2007","journal-title":"EMBO Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12943-023-01826-7","article-title":"Reigniting hope in cancer treatment: The promise and pitfalls of IL-2 and IL-2R targeting strategies","volume":"22","author":"Muhammad","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Rokade, S., Damani, A.M., Oft, M., and Emmerich, J. (2024). IL-2 based cancer immunotherapies: An evolving paradigm. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1433989"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Kaur, K., Chen, P.-C., Ko, M.-W., Mei, A., Senjor, E., Malarkannan, S., Kos, J., and Jewett, A. (2023). Sequential therapy with supercharged NK cells with either chemotherapy drug cisplatin or anti-PD-1 antibody decreases the tumor size and significantly enhances the NK function in Hu-BLT mice. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1132807"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1615\/CritRevImmunol.2023050618","article-title":"Supercharged NK Cell-Based Immuotherapy in Humanized Bone Marrow Liver and Thymus (Hu-BLT) Mice Model of Oral, Pancreatic, Glioblastoma, Hepatic, Melanoma and Ovarian Cancers","volume":"43","author":"Kaur","year":"2023","journal-title":"Crit. Rev. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Kaur, K., Chang, H.H., Cook, J., Eibl, G., and Jewett, A. (2017). Suppression of Gingival NK Cells in Precancerous and Cancerous Stages of Pancreatic Cancer in KC and BLT-Humanized Mice. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.01606"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jri.2010.11.005","article-title":"Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection","volume":"88","author":"Olesen","year":"2011","journal-title":"J. Reprod. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/JVI.06120-11","article-title":"Generation of HIV latency in humanized BLT mice","volume":"86","author":"Denton","year":"2012","journal-title":"J. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1101\/pdb.top073585","article-title":"Human cancer growth and therapy in immunodeficient mouse models","volume":"2014","author":"Shultz","year":"2014","journal-title":"Cold Spring Harb. Protoc."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00262-016-1822-9","article-title":"Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice","volume":"65","author":"Kozlowska","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Kaur, K., Topchyan, P., and Jewett, A. (2025). Supercharged Natural Killer (sNK) Cells Inhibit Melanoma Tumor Progression and Restore Endogenous NK Cell Function in Humanized BLT Mice. Cancers, 17.","DOI":"10.21203\/rs.3.rs-6792338\/v1"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1182\/blood-2024-202959","article-title":"Bone Marrow Stromal Cells Hamper Leukemia Cell Induced NK Cell Activation and Cytotoxicity","volume":"144","author":"Decombis","year":"2024","journal-title":"Blood"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.31557\/APJCP.2020.21.10.2949","article-title":"Impact of Bone Marrow Natural Killer Cells (NK); Soluble TNF-\u03b1 and IL-32 Levels in Myelodysplastic Syndrome Patients","volume":"21","author":"Aref","year":"2020","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Shupp, A.B., Kolb, A.D., Mukhopadhyay, D., and Bussard, K.M. (2018). Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts. Cancers, 10.","DOI":"10.3390\/cancers10060182"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41392-024-01885-2","article-title":"Mechanism insights and therapeutic intervention of tumor metastasis: Latest developments and perspectives","volume":"9","author":"Shi","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Martiniakova, M., Mondockova, V., Biro, R., Kovacova, V., Babikova, M., Zemanova, N., Ciernikova, S., and Omelka, R. (2023). The link between bone-derived factors osteocalcin, fibroblast growth factor 23, sclerostin, lipocalin 2 and tumor bone metastasis. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1113547"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41568-021-00406-5","article-title":"Evolving cancer\u2013niche interactions and therapeutic targets during bone metastasis","volume":"22","author":"Satcher","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41413-020-00105-1","article-title":"Molecular mechanisms and clinical management of cancer bone metastasis","volume":"8","author":"Wang","year":"2020","journal-title":"Bone Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1152\/physrev.00012.2019","article-title":"Bone metastasis: Mechanisms, therapies, and biomarkers","volume":"101","author":"Coleman","year":"2021","journal-title":"Physiol. Rev."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"111203","DOI":"10.1016\/j.injury.2023.111203","article-title":"Cytokines: The links between bone and the immune system","volume":"55","author":"Cai","year":"2024","journal-title":"Injury"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Di Pompo, G., Errani, C., Gillies, R., Mercatali, L., Ibrahim, T., Tamanti, J., Baldini, N., and Avnet, S. (2021). Acid-Induced Inflammatory Cytokines in Osteoblasts: A Guided Path to Osteolysis in Bone Metastasis. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.678532"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Xu, J., Yu, L., Liu, F., Wan, L., and Deng, Z. (2023). The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: A review. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1222129"},{"key":"ref_93","first-page":"000581","article-title":"Mining genome traits that determine the different gut colonization potential of Lactobacillus and Bifidobacterium species","volume":"7","author":"Xiao","year":"2021","journal-title":"Microb Genom"},{"key":"ref_94","first-page":"03.20.644481","article-title":"Lactobacillus acidophilus ameliorates inflammatory bone loss under post-menopausal osteoporotic conditions via preventing the pathogenic conversion of gut resident pTregs into Th17 cells","volume":"2025","author":"Bhardwaj","year":"2025","journal-title":"bioRxiv"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"100919","DOI":"10.1016\/j.focha.2025.100919","article-title":"A review on probiotics and dietary bioactives: Insights on metabolic well-being, gut microbiota, and inflammatory responses","volume":"6","author":"Mafe","year":"2025","journal-title":"Food Chem. Adv."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1128\/microbiolspec.BAD-0015-2016","article-title":"The Potential of Probiotics as a Therapy for Osteoporosis","volume":"5","author":"Collins","year":"2017","journal-title":"Microbiol. Spectr."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Rodriguez-Arrastia, M., Martinez-Ortigosa, A., Rueda-Ruzafa, L., Folch Ayora, A., and Ropero-Padilla, C. (2021). Probiotic Supplements on Oncology Patients\u2019 Treatment-Related Side Effects: A Systematic Review of Randomized Controlled Trials. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18084265"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e24148","DOI":"10.1200\/JCO.2024.42.16_suppl.e24148","article-title":"Effect of probiotics on quality of life for patients with cancer undergoing immunotherapy","volume":"42","author":"Espinoza","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Lei, W., Zhou, K., Lei, Y., Li, Q., and Zhu, H. (2025). Gut microbiota shapes cancer immunotherapy responses. Npj Biofilms Microbiomes, 11.","DOI":"10.1038\/s41522-025-00786-8"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.medj.2024.07.014","article-title":"Preclinical assessment for translation to humans: The PATH approach for assessing supporting evidence for early-phase trials and innovative care","volume":"5","author":"Kimmelman","year":"2024","journal-title":"Med"},{"key":"ref_101","first-page":"47","article-title":"Gut Microbiota-Bone Axis","volume":"81","author":"Indrio","year":"2025","journal-title":"Ann. Nutr. Metab."},{"key":"ref_102","first-page":"373","article-title":"Gut-bone axis perturbation: Mechanisms and interventions via gut microbiota as a primary driver of osteoporosis","volume":"50","author":"Wei","year":"2025","journal-title":"J. Orthop. Transl."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Im\u0161irovi\u0107, V., Wensveen, F.M., Poli\u0107, B., and Jelen\u010di\u0107, V. (2024). Maintaining the Balance: Regulation of NK Cell Activity. Cells, 13.","DOI":"10.3390\/cells13171464"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Liu, Q., Zhao, J., and Song, D. (2025). The roles of natural killer cells in bone and arthritic disease: A narrative review. Immunol. Med., 1\u201314.","DOI":"10.1080\/25785826.2025.2506260"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12964-025-02299-5","article-title":"Common mechanisms of Gut microbe-based strategies for the treatment of intestine-related diseases: Based on multi-target interactions with the intestinal barrier","volume":"23","author":"Chen","year":"2025","journal-title":"Cell Commun. Signal."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.4014\/jmb.2205.05041","article-title":"The Functional Roles of Lactobacillus acidophilus in Different Physiological and Pathological Processes","volume":"32","author":"Gao","year":"2022","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Zhao, W., Liu, Y., Kwok, L.-Y., Cai, T., and Zhang, W. (2020). The immune regulatory role of Lactobacillus acidophilus: An updated meta-analysis of randomized controlled trials. Food Biosci., 36.","DOI":"10.1016\/j.fbio.2020.100656"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Renukadevi, J., Helinto, J.S., and Prena, D. (2025). Immunotherapeutic Potential of Lactobacillus Species as Immune Checkpoint Inhibitors in Cancer Immunotherapy. J. Bio-X Res., 8.","DOI":"10.34133\/jbioxresearch.0028"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/COC.0000000000001158","article-title":"Efficacy and Safety of Probiotics as Adjunctive Therapy in Cancer Treatment: A Comprehensive Systematic Review and Meta-Analysis","volume":"48","author":"Qureshi","year":"2025","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"100111","DOI":"10.1016\/j.medmic.2024.100111","article-title":"Insights of probiotics as an alternative medicine for cancer therapy, mechanism, and applications","volume":"22","author":"Mukherjee","year":"2024","journal-title":"Med. Microecol."},{"key":"ref_111","first-page":"41","article-title":"Activation of Natural Killer Cells by Probiotics","volume":"7","author":"Aziz","year":"2016","journal-title":"Onco Ther."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41430-020-0670-z","article-title":"Effects of probiotic supplementation on natural killer cell function in healthy elderly individuals: A meta-analysis of randomized controlled trials","volume":"74","author":"Gui","year":"2020","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11914-020-00591-6","article-title":"Are Probiotics the New Calcium and Vitamin D for Bone Health?","volume":"18","author":"Rizzoli","year":"2020","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"101067","DOI":"10.1016\/j.fochx.2023.101067","article-title":"Probiotic-driven advancement: Exploring the intricacies of mineral absorption in the human body","volume":"21","author":"Varvara","year":"2024","journal-title":"Food Chem. X"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"595962","DOI":"10.1155\/2014\/595962","article-title":"Effect of probiotics supplementation on bone mineral content and bone mass density","volume":"2014","author":"Parvaneh","year":"2014","journal-title":"Sci. World J."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"10405","DOI":"10.1073\/pnas.1533207100","article-title":"Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator","volume":"100","author":"Cenci","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/jcb.10074","article-title":"Characterization of interferon gamma receptors on osteoclasts: Effect of interferon gamma on osteoclastic superoxidegeneration","volume":"84","author":"Yang","year":"2002","journal-title":"J. Cell Biochem."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1096\/fasebj.14.3.523","article-title":"Best5: A novel interferon-inducible gene expressed during bone formation","volume":"14","author":"Grewal","year":"2000","journal-title":"FASEB J."},{"key":"ref_119","first-page":"4696","article-title":"The role of IFN-gamma in rejection of established tumors by IL-12: Source of production and target","volume":"62","author":"Segal","year":"2002","journal-title":"Cancer Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1165\/ajrcmb.22.4.3336","article-title":"Local activation of nonspecific defense against a respiratory model infection by application of interferon- gamma: Comparison between rat alveolar and interstitial lung macrophages","volume":"22","author":"Steinmuller","year":"2000","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1074\/jbc.M804812200","article-title":"Interferon-gamma targets cancer cells and osteoclasts to prevent tumor-associated bone loss and bone metastases","volume":"284","author":"Xu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/BOR.0b013e32805e87e0","article-title":"The role of T cells in rheumatoid arthritis: New subsets and new targets","volume":"19","author":"Toh","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"8226","DOI":"10.4049\/jimmunol.177.11.8226","article-title":"Synovial autoreactive T cells in rheumatoid arthritis resist IDO-mediated inhibition","volume":"177","author":"Zhu","year":"2006","journal-title":"J. Immunol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.4049\/jimmunol.177.12.8844","article-title":"Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis","volume":"177","author":"Wan","year":"2006","journal-title":"J. Immunol."},{"key":"ref_125","first-page":"859","article-title":"Immunosuppression by melanoma cells as a factor in the generation of metastatic disease","volume":"9","author":"Cochran","year":"1989","journal-title":"Anticancer Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02587.x","article-title":"Cancer immunoediting from immune surveillance to immune escape","volume":"121","author":"Kim","year":"2007","journal-title":"Immunology"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00262-006-0257-0","article-title":"Immune reconstitution prevents metastatic recurrence of murine osteosarcoma","volume":"56","author":"Merchant","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Li, S., Liu, G., and Hu, S. (2024). Osteoporosis: Interferon-gamma-mediated bone remodeling in osteoimmunology. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1396122"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Tang, M., Tian, L., Luo, G., and Yu, X. (2018). Interferon-Gamma-Mediated Osteoimmunology. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01508"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s40778-018-0139-3","article-title":"The Role of Interferon-Gamma in Hematopoietic Stem Cell Development, Homeostasis, and Disease","volume":"4","author":"King","year":"2018","journal-title":"Curr. Stem Cell Rep."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"156046","DOI":"10.1016\/j.prp.2025.156046","article-title":"The paradoxical role of IFN-\u03b3 in cancer: Balancing immune activation and immune evasion","volume":"272","author":"Liu","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1182\/blood-2014-04-568451","article-title":"Impact of interferon-\u03b3 on hematopoiesis","volume":"124","author":"Voermans","year":"2014","journal-title":"Blood"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/17\/1347\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:35:37Z","timestamp":1760034937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/17\/1347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":132,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cells14171347"],"URL":"https:\/\/doi.org\/10.3390\/cells14171347","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]}}}